Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Resonance Health Ltd (RHT) vs. Competitors

3 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:RHTResonance Health LtdAUD 0.08AUD 44.84M25.0063.27%―Unlock the AU:RHT analyst price target with TipRanks PremiumAU:RHTUnlock the AU:RHT top-analyst price target with TipRanks Premium
AU:PMEPro Medicus LimitedAUD 187.76AUD 20.12B73.92-25.80%Strong BuyUnlock the AU:PME analyst price target with TipRanks PremiumAU:RHT vs AU:PMEUnlock the AU:PME top-analyst price target with TipRanks Premium
AU:M7TMach7 TechnologiesAUD 0.26AUD 61.10M-6.71-27.14%Moderate BuyUnlock the AU:M7T analyst price target with TipRanks PremiumAU:RHT vs AU:M7TUnlock the AU:M7T top-analyst price target with TipRanks Premium
AU:BMTBeamtree Holdings LtdAUD 0.07AUD 20.08M-1.03-67.50%Moderate BuyUnlock the AU:BMT analyst price target with TipRanks PremiumAU:RHT vs AU:BMTUnlock the AU:BMT top-analyst price target with TipRanks Premium
AU:SHGSingular Health Group LtdAUD 0.19AUD 60.33M-9.11-32.73%Moderate BuyUnlock the AU:SHG analyst price target with TipRanks PremiumAU:RHT vs AU:SHGUnlock the AU:SHG top-analyst price target with TipRanks Premium
AU:AYAArtrya LimitedAUD 2.49AUD 425.86M-14.31-21.45%Strong BuyUnlock the AU:AYA analyst price target with TipRanks PremiumAU:RHT vs AU:AYAUnlock the AU:AYA top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:RHTResonance Health Ltd0.080.0486.05%
AU:PMEPro Medicus Limited187.76-62.34-24.92%
AU:M7TMach7 Technologies0.26-0.11-30.14%
AU:BMTBeamtree Holdings Ltd0.07-0.14-67.50%
AU:SHGSingular Health Group Ltd0.18-0.08-28.85%
AU:AYAArtrya Limited2.49-0.38-13.24%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts